PuriCore Appoints Financial Adviser and Corporate Broker

MALVERN, Pa. & STAFFORD, England--(Business Wire)--
PuriCore (LSE:PURI), the life sciences company focused on developing and
commercializing proprietary, green solutions that safely, effectively, and
naturally kill infectious pathogens without causing harm to human health or the
environment, today announces the appointment of Piper Jaffray Ltd. as its
Financial Adviser and Corporate Broker to the Company effective immediately.

About PuriCore

PuriCore plc (LSE: PURI) is a life sciences company focused on developing and
commercializing proprietary green solutions that safely, effectively, and
naturally kill infectious pathogens without causing harm to human health or the
environment. PuriCore`s patented, proprietary technology mimics the human body`s
production of the natural antimicrobial hypochlorous acid, offering a safe and
non-hazardous approach to disinfection and sanitisation. The Company`s products
are used in a broad range of markets that depend upon controlling contamination,
including food retail and foodservice, medical device disinfection, and wound
care. Hypochlorous acid is proven to be safe, environmentally friendly, and fast
acting against a broad range of infectious pathogens, including major public
health threats of C.difficile, E.coli, HIV, Human and Animal Influenza
(including H1N1 and H5N1), Legionella, MRSA, M.tuberculosis, Norovirus, and
Salmonella. PuriCore is headquartered in Malvern, Pennsylvania, with offices in
Stafford and Clevedon, UK.

To receive additional information on PuriCore, please visit our website at
www.puricore.com, which does not form part of this press release.

Sage Strategic Marketing
Jennifer Guinan
610-410-8111
Jennifer@sagestrat.com
or
PuriCore
Greg Bosch, CEO
Darren Weiss, CFO
484-321-2700
or
Piper Jaffray Ltd.
Jamie Adams
Michael Covington
+44 (0) 20 3142 8700

Copyright Business Wire 2009